Breast cancers that highly expressed these cancer-specific PERK genes were significantly more likely to develop distant metastases over 10 years (HR = 1.8, p < 0.005, log-rank test; Fig. 1c). This evidence concerns the gene EIF2AK3 and breast cancer.